The Pharmaceutical Licensing Group in conjunction with the University of Manchester runs a modular distance learning course which can result in an award of an MSc, Diploma or Certificate in Business Development in the healthcare industry.
This course offers a range of modules which can be studied sequentially to secure a full MSc qualification (eight modules completed in four years, plus an extra year for dissertation), a Diploma (eight modules completed in four years) or a Certificate (four units completed in two years).
Each module accounts for 15 M level credits; each consists of 150hours study, (consisting of 10 direct contact hours, 70 hours distance learning and 70 hours individual private study).
The eight modules comprise:
This introductory module provides an overview of the industry including units on the structure and dynamics of the industry, R&D and drug discovery and development including basic regulatory concepts. It addresses company strategies and the external factors which impact on the industry’s future. More information (PDF)
This module covers the key operational areas within business development and licensing including units on portfolio management, partnering processes, due diligence and alliance management. In addition, the module also has units on technology transfer and R&D agreements including Lambert agreements and clinical trial agreements. More information (PDF)
This module covers basic financial concepts including company accounts and cash flow and the key tools required for financial evaluation of businesses and deals. There are also units covering financial modelling using Excel, valuation techniques (both financial and benchmark methods), sales forecasts and the management of risk. More information (PDF)
This module covers the fundamental concepts of law as well as the key legal aspects required to support the negotiation and conclusion of all types of agreements in the healthcare industry. The unit includes all type of agreements, ranging from CDAs to supply as well as fundamental issues such as product development, marketing, performance, competition law and product liability. More information (PDF)
This module covers the development of the interpersonal skills required for successful negotiation. Particular emphasis is placed on developing negotiation and communication skills and expertise in different negotiating environments and includes organisational cultures and behaviour; national and corporate cultural issues and planning and management of negotiations. More information (PDF)
This module covers all aspects of national and international commercialisation of products and technologies. The units include, marketing strategies, market intelligence and competition pricing, co-promotion and generics. More information (PDF)
This module covers all aspects of Intellectual Property including patents, know-how, trademarks, trade secrets and copyright. Concepts, regulations and processes are explained together with the licensing and exploitation of IP in the healthcare industry. More information (PDF)
This module covers the nuts and bolts of bioscience R&D and manufacturing. Four of the 8 units of the module explain each stage of the drug development process from discovery through to clinical development. The four manufacturing units include primary, secondary and biopharmaceutical manufacturing and QA. More information (PDF)
All the PIAT BD&L modules have been written on the basis that the UK is part of the EU. In June 2016 the UK indicated an intention to leave the EU. At the moment (July 2016) the new arrangements between the UK and the EU are not known. Over the next two years, 2017 and 2018, the modules will be updated as more information about the new arrangements are finalised.
For further information on all PLG Training courses please visit Medius Associates or contact:
Tel: +44 (0) 7850 942806
For further information on the University of Manchester’s post graduate training please visit University of Manchester Pharmacy School